NanoViricides, Inc. (NNVC)
NYSEAMERICAN: NNVC · Real-Time Price · USD
1.330
+0.020 (1.53%)
Aug 21, 2026, 4:00 PM EDT - Market closed
NanoViricides Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 3.21 | 1.56 | 4.8 | 8.15 | 14.07 | 20.52 |
Cash & Short-Term Investments | 3.21 | 1.56 | 4.8 | 8.15 | 14.07 | 20.52 |
Cash Growth | 26.38% | -67.52% | -41.13% | -42.06% | -31.44% | 49.66% |
Prepaid Expenses | 0.16 | 0.11 | 0.17 | 0.3 | 0.35 | 0.31 |
Total Current Assets | 3.38 | 1.67 | 4.97 | 8.45 | 14.42 | 20.82 |
Property, Plant & Equipment | 6.53 | 6.83 | 7.51 | 8.11 | 8.69 | 9.08 |
Other Intangible Assets | 0.31 | 0.32 | 0.33 | 0.33 | 0.34 | 0.35 |
Other Long-Term Assets | 0 | 0 | 0.01 | 0.01 | 0.04 | 0 |
Total Assets | 10.22 | 8.82 | 12.82 | 16.9 | 23.49 | 30.26 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 0.13 | 0.46 | 0.38 | 0.16 | 0.06 | 0.2 |
Accrued Expenses | 0.03 | 0.03 | 0.26 | 0.14 | 0.05 | 0.02 |
Short-Term Debt | - | - | - | - | 0.09 | 0.1 |
Other Current Liabilities | 0.9 | 0.82 | 0.72 | 0.23 | 0.21 | 0.03 |
Total Current Liabilities | 1.07 | 1.31 | 1.36 | 0.53 | 0.41 | 0.35 |
Other Long-Term Liabilities | - | - | - | 1.5 | - | - |
Total Liabilities | 1.07 | 1.31 | 1.36 | 2.03 | 0.41 | 0.35 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0.01 |
Additional Paid-In Capital | 163.99 | 156.36 | 150.84 | 145.95 | 145.57 | 144.28 |
Retained Earnings | -154.84 | -148.84 | -139.37 | -131.08 | -122.49 | -114.39 |
Total Common Equity | 9.15 | 7.52 | 11.46 | 14.87 | 23.08 | 29.91 |
Shareholders' Equity | 9.15 | 7.52 | 11.46 | 14.87 | 23.08 | 29.91 |
Total Liabilities & Equity | 10.22 | 8.82 | 12.82 | 16.9 | 23.49 | 30.26 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | - | - | - | - | 0.09 | 0.1 |
Net Cash (Debt) | 3.21 | 1.56 | 4.8 | 8.15 | 13.97 | 20.42 |
Net Cash Growth | 26.38% | -67.52% | -41.13% | -41.67% | -31.58% | 62.54% |
Net Cash Per Share | 0.17 | 0.10 | 0.40 | 0.70 | 1.21 | 1.87 |
Filing Date Shares Outstanding | 21.65 | 17.43 | 14.68 | 11.75 | 11.59 | 11.52 |
Total Common Shares Outstanding | 21.65 | 16.61 | 13.14 | 11.7 | 11.59 | 11.52 |
Working Capital | 2.31 | 0.36 | 3.61 | 7.91 | 14 | 20.47 |
Book Value Per Share | 0.42 | 0.45 | 0.87 | 1.27 | 1.99 | 2.60 |
Tangible Book Value | 8.84 | 7.2 | 11.14 | 14.53 | 22.74 | 29.56 |
Tangible Book Value Per Share | 0.41 | 0.43 | 0.85 | 1.24 | 1.96 | 2.57 |
Land | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 |
Machinery | 6.6 | 6.6 | 6.54 | 6.38 | 6.25 | 6.05 |